Completed NA INTERVENTIONAL 2-arm
NCT04739228
Effects of Guided Written Disclosure Protocol on Psychological Distress and Positive Functioning in Persons With Skin Diseases: a Randomized-controlled Trial
Sponsor: European University of Rome
Interventions
Active Control Group Guided Written Disclosure Protocol Group
Updated 3 times since 2021 Last updated: Feb 3, 2021 Started: Jul 1, 2017 Primary completion: Mar 1, 2020 Completion: Mar 1, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT04739228, this NA trial focuses on Disclosure and Emotional Stress and remains completed. Sponsored by European University of Rome, it has been updated 3 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
3 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Mar 2021 — Jul 2024 [monthly]
Completed NA
First recorded
Jul 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- European University of Rome
- IRCSS Istituto Dermopatico dell'Immacolata, Fondazione Luigi Maria Monti
Data source: European University of Rome
For direct contact, visit the study record on ClinicalTrials.gov .